Several leading companies worldwide focus on the synthesis of complex medicinal APIs, notably Abacavir sulfate, Abarelix, and Abiraterone. These substances present significant hurdles in process creation due to their structural complexity. The manufacturers of these APIs often employ sophisticated methods and adhere to strict regulatory protocols t